1/23
Health Sciences
Penn Medicine Study Reveals Profile of Patients Most Likely to Delay Hospice Enrollment Until Final Days of Life
One in six cancer patients enroll in hospice only during their last three days of life, according to a new study from a team from the Perelman School of Medicine at the University of Pennsylvania.
Penn Medicine: Zebrafish Model of a Learning and Memory Disorder Shows Better Way to Target Treatment
Using a zebrafish model of a human genetic disease called neurofibromatosis (NF1), a team from the Perelman School of Medicine at the University of Pennsylvania has found that the learning and memory components of the disorder are distinct features that will likely need different treatment approaches.
Penn Medicine Study Reveals Profile of Patients Most Likely to Delay Hospice Enrollment Until Final Days of Life
One in six cancer patients enroll in hospice only during their last three days of life, according to a new study from a team from the Perelman School of Medicine at the University of Pennsylvania.
Penn Researcher and CVS Health Physician Urge New Payment Model for Costly Gene Therapy Treatments
Hoping to encourage sufficient investments by pharmaceutical companies in expensive gene therapies, which often consist of a single treatment, a Penn researcher and the chief medical officer of CVS Health outline an alternative payment model in this month’s issue of Nature Biotechnology.
Penn Research Shows How Brain Can Tell Magnitude of Errors
University of Pennsylvania researchers have made another advance in understanding how the brain detects errors caused by unexpected sensory events. This type of error detection is what allows the brain to learn from its mistakes, which is critical for improving fine motor control.
Penn Study Finds Genetic Mutations Linked With Ethnic Disparities in Cancer
One of the goals of genome sequencing is to identify genetic mutations associated with increased susceptibility to disease. Yet by and large these discoveries have been made in people of European or Asian ancestry, resulting in an incomplete picture of global genetic variation in disease vulnerability.
Penn Team Finds Ovarian Cancer Oncogene in 'Junk DNA'
Over the years researchers have made tremendous strides in the understanding and treatment of cancer by searching genomes for links between genetic alterations and disease.
Penn Study Shows Better Outcomes for Sepsis Patients Treated in Hospitals with Higher Volume of Cases
Patients with sepsis, one of the most time-sensitive and hard-to-detect illnesses in medicine, are more likely to survive the life-threatening condition when treated at a hospital that sees a higher volume of sepsis cases.
Penn Medicine Study: Attacking a Rare Disease at its Source With Gene Therapy
Treating the rare disease MPS I is a challenge. MPS I, caused by the deficiency of a key enzyme called IDUA, eventually leads to the abnormal accumulation of certain molecules and cell death.
In the News
6ABC.com
Bird flu suspected in deaths of 200 snow geese in Pennsylvania’s Lehigh Valley
Stephen Cole of the School of Veterinary Medicine says that indoor cats are contracting bird flu through raw pet foods of poultry origin or raw milk products.
FULL STORY →
Self
The surgeon general calls for new warning labels on alcohol—here’s the truth about how it impacts your health
Henry Kranzler of the Perelman School of Medicine says that alcohol’s effects on the brain are observed more readily because it’s the organ of behavior.
FULL STORY →
NPR
Tuberculosis rates plunge when families living in poverty get a monthly cash payout
Aaron Richterman of the Perelman School of Medicine says that there are large and underappreciated benefits of cash-transfer programs, such as potentially ending a tuberculosis epidemic.
FULL STORY →
Time
Scientists are racing to develop a new bird flu vaccine
Drew Weissman and Scott Hensley of the Perelman School of Medicine are testing a vaccine to prevent a strain of H5N1 bird flu in chickens and cattle.
FULL STORY →
Newsweek
Cancer breakthrough as ‘speckles’ may reveal best treatment
A paper co-authored by PIK Professor Shelley Berger finds that patterns of “speckles” in the heart of tumor cells could help predict how patients with a common form of kidney cancer will respond to treatment options.
FULL STORY →